DeepRhythmAI vs iCAC Device

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

DeepRhythmAI

by Medicalgorithmics

iCAC Device

by Bunkerhill Health

AI Verdict

These two tools are adjacent in the cardiology AI space, both being FDA-cleared and cloud-based. DeepRhythmAI specializes in the detection and classification of cardiac arrhythmias from ECG data, while the iCAC Device focuses on identifying and quantifying coronary artery calcium from chest CT scans. Therefore, DeepRhythmAI is suited for rhythm disorder diagnostics, whereas the iCAC Device aids in early cardiovascular disease risk assessment based on anatomical calcification.

Choose DeepRhythmAI if…

Choose DeepRhythmAI if your primary need is highly accurate and efficient AI-powered analysis of ECG data for the detection and classification of cardiac arrhythmias. This cloud-based solution is ideal for healthcare providers seeking to significantly reduce missed diagnoses and streamline their clinical workflows for ECG reporting, regardless of the ECG device used.

View DeepRhythmAI →

Choose iCAC Device if…

Choose the iCAC Device if you aim to leverage existing non-contrast chest CT scans for opportunistic screening and quantification of coronary artery calcium, providing valuable adjunctive information for early cardiovascular disease detection. This tool is particularly beneficial for radiology and cardiology departments looking to enhance risk assessment by integrating automated CAC analysis into their routine imaging workflows.

View iCAC Device →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	DeepRhythmAI	iCAC Device
Pricing	Contact vendor for pricing information	Contact for pricing
Deployment	Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid	Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DeepRhythmAI

DeepRhythmAI is cloud-based, offers an API for integration, and is device-agnostic, supporting various ECG devices. It explicitly mentions an 'intuitive user interface' and 'workflow automation to minimize manual reviews,' along with support for English, Polish, and other European languages, suggesting a strong focus on user experience and broad accessibility.

Clinical Value

DeepRhythmAI

Both tools are FDA-cleared and provide significant clinical value in cardiology. However, DeepRhythmAI stands out with a quantifiable claim of '14 times lower risk of missed diagnosis compared to the current standard in ECG analysis,' which translates to a substantial improvement in diagnostic accuracy and patient outcomes.

Pricing & Value

Tie

Neither DeepRhythmAI nor iCAC Device provides transparent pricing information in the structured facts or through web searches. Both require direct contact for pricing details, making it impossible to compare their value propositions based on cost.

Enterprise Readiness

DeepRhythmAI

Both tools demonstrate strong enterprise readiness with cloud deployment, integration capabilities, and robust compliance certifications like HIPAA, SOC 2, and ISO 27001. DeepRhythmAI, founded in 2005, has a longer operational history and explicitly targets 'Solo to large health systems' with 'Numerous healthcare providers globally,' indicating a more established and widely adopted enterprise solution.

Innovation

DeepRhythmAI

Both tools leverage advanced AI. DeepRhythmAI utilizes cutting-edge CNN and Transformer models, trained on an exceptionally large dataset of '250 billion+ annotated heartbeats.' Its distinction as the 'First and Only FDA-Cleared (QYX) AI Integration Solution' for third-party software highlights a unique innovative approach to broad system integration.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer specific details regarding customer support channels, service level agreements, or comprehensive documentation beyond regulatory filings for either DeepRhythmAI or iCAC Device. Therefore, it is not possible to distinguish between the two tools on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	DeepRhythmAI	iCAC Device
Name	DeepRhythmAI	iCAC Device
Company	Medicalgorithmics S.A.	Bunkerhill Health
Description	FDA-cleared, cloud-based AI algorithm that revolutionizes cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians.	FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection.
Key Functionality	AI-powered arrhythmia detection and classification from ECG data.	Estimates presence and quantity of coronary artery calcium (CAC) from chest CT scans.
Target User/System Size	Solo to large health systems	Not specified
API Available	yes	Not specified
Data Export	yes	Not specified

Videos

Demos, reviews, and walkthroughs featuring DeepRhythmAI and iCAC Device.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of DeepRhythmAI and iCAC Device?

DeepRhythmAI is designed to revolutionize cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians. The iCAC Device detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection.

What types of patient data do these AI tools analyze?

DeepRhythmAI analyzes electrocardiogram (ECG) data for arrhythmia detection and classification. The iCAC Device analyzes routine, non-contrast, non-gated chest CT scans to estimate coronary artery calcium.

Which medical specialties are these tools intended to support?

DeepRhythmAI is primarily focused on cardiology, providing AI-powered ECG analysis. The iCAC Device supports both cardiology and radiology specialties by offering adjunctive information to radiologists and aiding in cardiovascular disease detection.

How do DeepRhythmAI and iCAC Device integrate into existing clinical workflows and IT infrastructure?

DeepRhythmAI is a cloud-based software with an available API, designed to be device-agnostic and integrate with various ECG devices. The iCAC Device is a Software as a Medical Device (SaMD) that integrates with PACS or a DICOM router, is cloud-based via the Carebricks platform, and supports EHR integration through Carebricks.

What specific diagnostic insights or outputs does each AI algorithm provide?

DeepRhythmAI provides AI-powered arrhythmia detection and classification, aiming for faster ECG reporting and analysis. The iCAC Device outputs a visual representation of estimated CAC segmentation and delivers exact and four-category quantitative estimates of CAC burden in Agatston units.

What are the key efficiency and accuracy benefits claimed by each tool?

DeepRhythmAI claims to reduce missed diagnoses by 14x to 114x fewer and streamline clinical workflows with up to a 65% efficiency increase in ECG analysis. The iCAC Device aids in early cardiovascular disease detection by supporting opportunistic identification of CAC from existing CT scans and providing adjunctive information to radiologists.